{"id":206634,"name":"TEVA PHARMACEUTICALS USA","slug":"teva-pharmaceuticals-usa","state":"DC","country":"United States of America","description":"Generic and biosimilar manufacturer.","totalSpending":1340000,"filings":25,"yearlySpending":[{"year":2020,"income":100000},{"year":2021,"income":220000},{"year":2022,"income":360000},{"year":2023,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":180000}],"issues":[{"code":"HCR","display":"Health Issues"},{"code":"MMM","display":"Medicare/Medicaid"},{"code":"PHA","display":"Pharmacy"},{"code":"TRD","display":"Trade (domestic/foreign)"}],"firms":["CAPITOL HILL CONSULTING GROUP"],"lobbyists":["BRIAN SUTTER","THOMAS WHARTON","EMILY WILKINSON-HOLLAND","WILLIAM SOUTHERLAND","CHRISTOPHER DAVIS","KIMBERLEE TRZECIAK"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Medicare reimbursement for biosimilars. Improving supply chain for products manufactured in the United States","Medicare reimbursement for biosimilars. Improving supply chain for products manufactured in the United States","Issues surrounding US Pharmaceutical supply chain","Issues surrounding US Pharmaceutical supply chain","Issues surrounding US Pharmaceutical supply chain"]}